Picture of Santhera Pharmaceuticals Holding AG logo

SANN — Santhera Pharmaceuticals Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Santhera And ReveraGen To Present New Data With Vamorolone

June 9 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG
 SANN.S :
    * SANTHERA AND REVERAGEN TO PRESENT NEW DATA WITH VAMOROLONE
AT
2022 PARENT PROJECT MUSCULAR DYSTROPHY CONFERENCE

Source text for Eikon:  ID:nGNE2nLT6V 
Further company coverage:  SANN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Santhera Pharmaceuticals Holding AG

See all news